Diagnosis
Fluorescein angiography allows for the identification and localization of abnormal vascular processes. Optical coherence tomography is now used by most ophthalmologists in the diagnosis and the followup evaluation of the response to treatment by using either bevacizumab (Avastin) or ranibizumab (Lucentis), which are injected into the vitreous humor of the eye at various intervals.
Recently, structured illumination light microscopy, using a specially designed super resolution microscope setup has been used to resolve the fluorescent distribution of small autofluorescent structures (lipofuscin granulae) in retinal pigment epithelium tissue sections.
Read more about this topic: Macular Degeneration